Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease

Phase 4

Terminated

Conditions: Chronic Kidney Disease

First Posted Date: 2005-09-19

Last Posted Date: 2008-03-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT00194961

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer

Phase 1

Terminated

Conditions: Head and Neck Cancer

First Posted Date: 2005-09-19

Last Posted Date: 2007-07-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 29

Registration Number: NCT00195078

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia

Phase 2

Completed

Conditions: Alloimmune Thrombocytopenia
Fetal Alloimmune Thrombocytopenia

Interventions: Drug: IVIG (Intravenous Immunoglobulin)
Drug: prednisone

First Posted Date: 2005-09-19

Last Posted Date: 2018-11-07

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 102

Registration Number: NCT00194987

Locations: 🇺🇸
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York, United States

Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML

Phase 1

Completed

Conditions: Myelodysplastic Syndrome

Interventions: Drug: Arsenic Trioxide (Tricenox)
Drug: Cytarabine

First Posted Date: 2005-09-19

Last Posted Date: 2017-03-03

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 87

Registration Number: NCT00195104

Locations: 🇺🇸
Weill Medcial College of Cornell University, New York, New York, United States

Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery

Phase 4

Completed

Conditions: Pain Management Following Cardiopulmonary Bypass Surgery

Interventions: Drug: Ketorolac
Other: Placebo

First Posted Date: 2005-09-12

Last Posted Date: 2009-05-13

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 25

Registration Number: NCT00161577

Locations: 🇺🇸
New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, United States

Pneumatic Displacement of Subretinal Hemorrhage With Perfluorocarbon Gases

Phase 2

Conditions: Subretinal Hemorrhage and Exudative Maculopathy

First Posted Date: 2005-09-12

Last Posted Date: 2011-01-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 25

Registration Number: NCT00161525

Locations: 🇺🇸
New York Presbyterian Hospital, New York, New York, United States

A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone

Phase 2

Withdrawn

Conditions: Idiopathic Thrombocytopenic Purpura (ITP)

First Posted Date: 2005-09-12

Last Posted Date: 2018-07-17

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT00161564

Locations: 🇺🇸
Weill Medical College of Cornell University Division of Pediatric Hematology-Oncology, New York, New York, United States

Use of Sucrose to Relieve Pain During Eye Exams in Infants

Not Applicable

Terminated

Conditions: Apnea of Prematurity
Retinopathy of Prematurity
Pain

First Posted Date: 2005-09-12

Last Posted Date: 2008-06-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 300

Registration Number: NCT00161694

Locations: 🇺🇸
NYPH - Weill Cornell Medical Center, New York, New York, United States

Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study

Completed

Conditions: Angioplasty Patients

First Posted Date: 2005-09-12

Last Posted Date: 2008-04-03

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 18

Registration Number: NCT00161603

Locations: 🇺🇸
The New York Presbyterian Hospital-Weill Medical Center, New York, New York, United States

Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma

Phase 1

Completed

Conditions: T-Cell Lymphoma
Lymphoma, Non-Hodgkin's

First Posted Date: 2005-09-12

Last Posted Date: 2008-10-22

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT00161590

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy